Skip to main content
. 2020 Oct 30;56(11):584. doi: 10.3390/medicina56110584

Table 5.

Strategies before changing ustekinumab.

Secondary Failure Arthritis Inefficacy Patients Intensified
Methotrexate added (n) (dose) 3 (15 mg/week) 3 (15 mg/week) 1 (15 mg/week)
Period between treatments shortened (n) (dose) 2 (90 mg/8 weeks)
2 (90 mg/10 weeks)
2 (90 mg/8 weeks)
Dose increased from 45 mg to 90 mg 1 5 8